Jajoria et al., in a study of 9 patients with APS treated with 40 mg of fluvastatin a day for 1 month, observed reduced levels of vascular endothelial growth factor (VEGF), TF, and TNF-α [129]. Here, VEGFA is linked to autoimmune polyendocrinopathy.